Risedronic Acid
Concept
Vocabulary Service
Overview
subject area of
-
14 day endoscopy study comparing risedronate and alendronate in postmenopausal women stratified by Helicobacter pylori status. Academic Article
-
In vitro disintegration studies of weekly generic and branded risedronate sodium formulations available in Canada Academic Article
-
Antiresorptive therapy conserves some periarticular bone and ligament mechanical properties after anterior cruciate ligament disruption in the rabbit knee Academic Article
-
Cost-effectiveness of Denosumab for the treatment of postmenopausal osteoporosis Academic Article
-
Cost-effectiveness of alternative treatments for women with osteoporosis in Canada Academic Article
-
Cost-effectiveness of denosumab in the treatment of postmenopausal osteoporosis in Canada Academic Article
-
Cost-effectiveness of romosozumab for the treatment of postmenopausal women at very high risk of fracture in Canada Academic Article
-
Denosumab Versus Risedronate in Glucocorticoid‐Induced Osteoporosis: Final Results of a Twenty‐Four–Month Randomized, Double‐Blind, Double‐Dummy Trial Academic Article
-
Denosumab versus risedronate in glucocorticoid-induced osteoporosis: a multicentre, randomised, double-blind, active-controlled, double-dummy, non-inferiority study Academic Article
-
Early Responsiveness of Women with Osteoporosis to Teriparatide After Therapy with Alendronate or Risedronate Academic Article
-
Efficacy of risedronate on clinical vertebral fractures within six months Academic Article
-
Endoscopic comparison of esophageal and gastroduodenal effects of risedronate and alendronate in postmenopausal women Academic Article
-
Greater first year effectiveness drives favorable cost-effectiveness of brand risedronate versus generic or brand alendronate: modeled Canadian analysis Academic Article
-
III. Meta-Analysis of Risedronate for the Treatment of Postmenopausal Osteoporosis Academic Article
-
Long-Term Tolerability of the Bisphosphonates in Postmenopausal Osteoporosis Academic Article
-
Mortality risk reduction differs according to bisphosphonate class: a 15-year observational study Academic Article
-
Oral bisphosphonates Academic Article
-
Osteonecrosis of the jaw: new developments in an old disease. Academic Article
-
Randomized, Double-Blinded, Placebo-Controlled, Trial of Risedronate for the Prevention of Bone Mineral Density Loss in Nonmetastatic Prostate Cancer Patients Receiving Radiation Therapy Plus Androgen Deprivation Therapy Academic Article
-
Reduced Bone Loss Is Associated With Reduced Mortality Risk in Subjects Exposed to Nitrogen Bisphosphonates: A Mediation Analysis Academic Article
-
Relationship Between Changes in Bone Mineral Density and Vertebral Fracture Risk Associated With Risedronate Academic Article
-
Review of the safety and efficacy of risedronate for the treatment of male osteoporosis. Academic Article
-
Risedronate for the prevention and treatment of postmenopausal osteoporosis. Academic Article
-
The Efficacy and Tolerability of Risedronate Once a week for the Treatment of Postmenopausal Osteoporosis Academic Article
-
Tolerability of Different Dosing Regimens of Bisphosphonates for the Treatment of Osteoporosis and Malignant Bone Disease Academic Article
-
Treating osteoporosis in Canada: what clinical efficacy data should be considered by policy decision makers? Academic Article
-
Vertebral fracture risk reduction with risedronate in post-menopausal women with osteoporosis: a meta-analysis of individual patient data Academic Article
-
[Are there differences in bisphosphonates? (interview by Dr. Beate Schumacher)]. Academic Article